Barker, C. A., Lanning, R. M., Koyfman, S. A., Liao, J. J., Parvathaneni, U., Chera, B., Galloway, T. J., Zakeri, K., Yu, Y., Chen, L., Shamseddine, A., Gelblum, D. Y., Ho, A. L., Lee, N. Y., Zhang, Z., Dunn, L. (2026). A phase II, multicenter, single-arm clinical trial of response-adapted definitive radiotherapy and cemiplimab-rwlc immunotherapy for locally advanced, unresectable cutaneous squamous cell carcinoma: RAMPART.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.9506